Promising results for Inovio

INOVIO's Dr. Kate Broderick Interview on Fox NewsПодробнее

Inovio's Hope For Defeating CancerПодробнее

Inovio Pharmaceuticals INO Q4 2023 Earnings PresentationПодробнее

INOVIO DNA Immunotherapy and GBMПодробнее

Inovio Pharmaceuticals INO Q3 2024 Earnings PresentationПодробнее

Inovio Pharmaceuticals (INO) announced positive results for phase 1/2 trial of INO-3107Подробнее

Kate Broderick: INO-4800 – A DNA based vaccine against COVID-19Подробнее

Covid-19 vaccine: Inovio shows promise in preliminary clinical trialsПодробнее

US biotech firm eyes human trial of Zika vaccine within 2016Подробнее

Trials show progress on COVID-19 immunity, vaccinesПодробнее

INOVIO begins phase 1 clinical trial for vaccineПодробнее

INOVIO's Phase 2 clinical trial underwayПодробнее

Inovio's COVID-19 Vaccine Set To Go Through Critical Stage Three TrialПодробнее

Inovio Coronavirus Vaccine Results Fall ShortПодробнее

Inovio Pharmaceuticals (INO) Stock positioned for a potential BULL RUNПодробнее

Inovio Pharmaceuticals (INO) scrapping 3 vaccines, but it didn’t tank. Is it still a buy?Подробнее

Experimental Glioblastoma Therapy Has Promise in Treatment-Resistant CancersПодробнее

Why Inovio Pharmaceuticals Plunged 20% TodayПодробнее

INOVIO PHARMACEUTICALS INC FDA REVERSED THE DECISION | INOVIO PHARMACEUTICALS STOCK FORECASTПодробнее